| Application no. and date | 10010301.9 (espacenet) (Federated) (European Patent Register), 20040616 | | Patent/reg. no. and date | DK/EP 2332921, 20160302 | | Publication date | 20110615 | | Priority no. and date | US 479280 P, 20030617, US 512967 P, 20031021 | | EP pub. no. and date |
EP 2332921 20110615 | | Effective date | | | Applicant/owner | Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive
San Diego, CA 92121, US | | Applicant ref. no. | P81601929DK00E | | Inventor | SMITH, Brian, 13182 Mesa Crest Place
San Diego, CA 92129, US,
AYTES, Shelley, 4518 Patria Drive
San Diego, CA 92115, US,
SENGUPTA, Dipanjan, 9121 Togan Avenue
San Diego, CA 92129, US,
Throop, Beverly W., 12761 Jordan Ridge Court
San Diego, CA 92130, US,
Weigl, Ulrich, Hans-Lochmann-Strasse 6
78247 Hilzingen, DE,
Gilson, Charles A., III., 4259 Del Mar Avenue
San Diego, CA 92107, US,
Rey, Max, .
(deceased), CH,
Estrade, Scott A., 953½ Thomas Avenue
San Diego, CA 92109, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61P 3/04 (2006.01) , C07D 223/16 (2006.01) | | Title | 8-Chlor-1-methyl-2,3,4,5-tetrahydro-1 H-3benzazepin-hydrochlorid | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
